Semaglutide & Liraglutide continue to be effective
Semaglutide and Liraglutide continue to be researched and studied and produce positive results for weight loss and medical outcomes.
GLP1 Receptor Agonists are well-researched class of drugs. Large studies and much research poured into efficacy and the quest to figure out side-effects of the drug.
Check out our quick explainer
While we often focus on many new formulations of GLP1 Receptor Agonists that are under research and due to be released (and possibly increase the supply of GLP1 RAs that are available), it's important to note that research is still ongoing into the existing formulations with impressive results continuously on display.
Semaglutide and Liraglutide (which now has a generic) still work great, and research continues to produce positive results.
The rest of this article is no longer available for free – if you'd like to read the rest of our analysis, check us out on Substack:
